Assessment of interlaboratory performance in external proficiency testing programs with a direct HDL-cholesterol assay.
Direct assays for the determination of HDL-cholesterol (HDL-C) have recently become available. The methods are precise, require small sample volume, and appear to be less affected by increased triglycerides than traditional precipitation methods. In this study, we describe the inter- and intralaboratory variability of the Boehringer Mannheim Corporation direct HDL-C assay and its performance in external proficiency testing surveys. A comparison study among three laboratories, using different analyzers and 85 serum specimens, showed a correlation coefficient (r) of 0.99. The direct HDL-C assay also showed good agreement with the ultracentrifugation-dextran sulfate-Mg2+ method (r = 0.98) and the Cholesterol Reference Method Laboratory Network-Designated Comparison Method (a = 0.98x + 4.75 mg/L, r = 0.98). Total error at medical decision levels ranged from -0.8% to +11.1%. Furthermore, this assay performed adequately in the College of American Pathologists and the ALERT surveys as well as the CDC Lipid Standardization Program and met all performance criteria of regulatory agencies.
Department of Laboratory Medicine, Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
N
N
Rifai
T G
TG
Cole
E
E
Iannotti
T
T
Law
M
M
Macke
R
R
Miller
D
D
Dowd
D A
DA
Wiebe
D002487:Centers for Disease Control and Prevention, U.S.; D008076:Cholesterol, HDL / Q000097:blood* / Q000592:standards; D003505:Cyclodextrins; D005215:Fasting; D006801:Humans; D007753:Laboratories / Q000592:standards; D008345:Manganese; D011786:Quality Control; D012016:Reference Values; D014481:United States; D047391:alpha-Cyclodextrins
D008076:Cholesterol, HDL; D003505:Cyclodextrins; D047391:alpha-Cyclodextrins; D008345:Manganese; C032613:alpha-cyclodextrin